These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4998018

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP, Ferguson JH.
    Thromb Diath Haemorrh; 1970 Oct 31; 24(1):1-9. PubMed ID: 4249468
    [No Abstract] [Full Text] [Related]

  • 6. Antifibrinolytic action of the anticoagulant split product of fibrinogen.
    Nanninga LB, Guest MM.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):526-32. PubMed ID: 5708130
    [No Abstract] [Full Text] [Related]

  • 7. [Inhibitors of fibrinolysis in the human placenta. Histochemical study].
    Fornasari PM, Sora A, Bolis PF, Guaschino S.
    Ann Ostet Ginecol Med Perinat; 1977 Jul 31; 98(2):104-7. PubMed ID: 855972
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K, Fukui I.
    Rinsho Byori; 1971 Mar 31; 19(3):223-6. PubMed ID: 4252723
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G.
    Minerva Ginecol; 1969 Jul 31; 21(14):888-92. PubMed ID: 4249426
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F, Klöcking HP.
    Biomed Biochim Acta; 1983 Jul 31; 42(6):725-30. PubMed ID: 6605748
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Isolation of peptides with anti-urokinase activity from the human placenta.
    Uszynski M.
    Thromb Haemost; 1980 Feb 29; 42(5):1411-6. PubMed ID: 6768150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.